Page last updated: 2024-10-27

fluoxetine and Cardiac Septal Defect

fluoxetine has been researched along with Cardiac Septal Defect in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research Excerpts

ExcerptRelevanceReference
"To investigate the safety of fluoxetine use during pregnancy, and to better understand the relationship between maternal fluoxetine use during the first trimester and congenital malformations in infants."4.95Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies. ( Gao, SY; Ji, C; Liu, CX; Shen, ZQ; Wu, QJ; Xu, X; Zhang, TN; Zhao, YH, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, SY1
Wu, QJ1
Zhang, TN1
Shen, ZQ1
Liu, CX1
Xu, X1
Ji, C1
Zhao, YH1

Reviews

1 review available for fluoxetine and Cardiac Septal Defect

ArticleYear
Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:10

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depression; Female; Fluoxetin

2017